Badgwell, D., Lu, Z., Cole, L., Fritsche, H., Atkinson, E. N., Somers, E., . . . Bast, R. C. (2007). Urinary Mesothelin Provides Greater Sensitivity for Early Stage Ovarian Cancer than Serum Mesothelin, Urinary hCG Free Beta Subunit and Urinary hCG Beta Core Fragment.
Chicago-stil citatBadgwell, Donna, et al. Urinary Mesothelin Provides Greater Sensitivity for Early Stage Ovarian Cancer Than Serum Mesothelin, Urinary HCG Free Beta Subunit and Urinary HCG Beta Core Fragment. 2007.
MLA-referensBadgwell, Donna, et al. Urinary Mesothelin Provides Greater Sensitivity for Early Stage Ovarian Cancer Than Serum Mesothelin, Urinary HCG Free Beta Subunit and Urinary HCG Beta Core Fragment. 2007.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.